Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Genmab
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Medical diagnosis of CTCL, and positivity for the CD4 receptor.
Early stage CTCL
Have received at least two prior therapies with inadequate effect, including phototherapy and/or electron beam, and/or chemotherapy.
Histopathological evidence of large cell transformation or poorly differentiated tumors or prior treatment with anti-CD4 monoclonal antibodies excluded participants from inclusion in the study.
You may not be if
Certain rare types of CTCL.
Previous treatment with other anti-CD4 medications.
More than two previous treatments with systemic chemotherapy.
Certain anti-psoriasis or anti-cancer therapies within the last 4 weeks before entering this trial.
Some types of steroid treatments less than two weeks before entering the trial.
Prolonged exposure to sunlight or UV light during the trial.
Other cancer diseases, except certain skin cancers or cervix cancer.
Chronic infectious disease requiring medication.
Certain serious medical conditions, including kidney or liver disease, some psychiatric illnesses, and stomach, lung, heart, hormonal, nerve or blood diseases.
Pregnant or breast-feeding women.
Women of childbearing age who are unable or unwilling to use an IUD or hormonal birth control during the whole trial.
If you are participating in another trial with a different new drug 4 weeks before you enter this trial.
